- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Angioimmunoblastic T-cell Lymphoma
Total 6794 results
-
Ruijin HospitalNot yet recruitingNK-T-Cell Lymphoma, ExtranodalChina
-
European Organisation for Research and Treatment...RecruitingStage IB-IIB Cutaneous T-Cell LymphomaSpain, United Kingdom, Denmark, Italy, France, Germany, Greece
-
Sichuan UniversityUnknown
-
Fudan UniversityUnknown
-
Institute of Hematology & Blood Diseases HospitalCancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing...UnknownNon-Hodgkin's Lymphoma | Peripheral T Cell Lymphoma | Relapsed or Refractory B Cell Non-Hodgkin's Lymphoma | Chronic Lymphoblastic LeukemiaChina
-
Yale UniversitySidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massey Cancer CenterWithdrawnLymphoma | Relapsed and Refractory Aggressive B- and T-cell LymphomasUnited States
-
Samsung Medical CenterCompletedRelapsed and/or Refractory Cutaneous T-cell LymphomaKorea, Republic of
-
M.D. Anderson Cancer CenterWithdrawnCutaneous T-cell Lymphoma
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Beijing Tongren HospitalRecruitingExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Sun Yat-sen UniversityNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
ImmuneOncia Therapeutics Inc.Active, not recruitingA Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal TypeExtranodal NK/T-cell Lymphoma, Nasal Type | Extranodal NK/T-cell LymphomaKorea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedExtranodal NK/T Cell Lymphoma, Nasal TypeChina
-
Ruijin HospitalActive, not recruitingExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Sun Yat-sen UniversityEli Lilly and CompanyUnknownExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Fudan UniversityUnknownExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Sun Yat-sen UniversityUnknownLymphoma, | Non-Hodgkin Lymphoma, | Extranodal NK/T-cell Lymphoma,Nasal-type,China
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruitingNK-Cell Leukemia | Extranodal NK T Cell LymphomaChina
-
Kyowa Kirin Co., Ltd.CompletedAdult T-cell Leukemia-lymphomaJapan
-
Falo, Louis, MDActive, not recruitingCutaneous T Cell LymphomaUnited States
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Mundipharma (China) Pharmaceutical Co. LtdCompletedRefractory Peripheral T-Cell Lymphoma | Relapsed T-Cell LymphomaChina
-
University of Michigan Rogel Cancer CenterWithdrawnCutaneous T Cell LymphomaUnited States
-
Stefan Schieke MDWithdrawnCutaneous T-cell Lymphoma (CTCL)United States
-
Florida Academic Dermatology CentersCelgene CorporationUnknownCutaneous T Cell LymphomaUnited States
-
Amir MortazaviNational Cancer Institute (NCI); Arno TherapeuticsCompletedStage III Multiple Myeloma | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse... and other conditionsUnited States
-
Won Seog KimSanofiRecruitingNatural Killer/T-cell Lymphoma | Relapsed Natural Killer/T-cell Lymphoma | Refractory Natural Killer/T-cell LymphomaKorea, Republic of
-
OnxeoCompletedCutaneous T-cell LymphomaAustria, France, Germany, Switzerland
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownRelapsed or Refractory Peripheral T-cell and NK/T-cell LymphomaChina
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Zhao WeiliNot yet recruiting
-
Ruijin HospitalRenJi Hospital; West China Hospital; Shandong Provincial Hospital; Tianjin Medical... and other collaboratorsNot yet recruitingPeripheral T Cell LymphomaChina
-
Second Affiliated Hospital, School of Medicine,...Ningbo No. 1 Hospital; Jinhua Central Hospital; Huizhou Municipal Central HospitalRecruiting
-
Shanghai Zhongshan HospitalTakeda; BeiGeneNot yet recruiting
-
Henan Cancer HospitalRecruitingPeripheral T-Cell LymphomaChina
-
Peking UniversityPeking University Cancer Hospital & InstituteNot yet recruitingNK/T Cell LymphomaChina
-
Antengene CorporationRecruitingPeripheral T-cell Lymphoma | NK/T-cell LymphomaChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory T-Cell Lymphoma | T Cell Lymphoma in RelapseChina
-
Genor Biopharma Co., Ltd.RecruitingPeripheral T Cell LymphomaChina
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
University of Colorado, DenverBristol-Myers SquibbActive, not recruitingPeripheral T Cell LymphomaUnited States
-
Innate PharmaCompletedCutaneous T-Cell LymphomaUnited States, France, Netherlands, United Kingdom
-
Conjupro Biotherapeutics, Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Withdrawn
-
Eli Lilly and CompanyCompletedCutaneous T-Cell LymphomaUnited States
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownPeripheral T Cell Lymphoma
-
Zhejiang Cancer HospitalUnknownPeripheral T Cell LymphomaChina
-
Eisai Co., Ltd.CompletedPeripheral T-Cell LymphomaJapan
-
The University of Hong KongUnknown
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States